News

The recent FDA approval of the oral JAK inhibitor could change the landscape of atopic dermatitis management.

Experts explain that their analysis clearly lays out how lack of effective regulation and an unchecked profit motive created the opioid epidemic.

Previous contrasting studies found that omalizumab was less effective in reducing exacerbations in obese patients.

No difference was observed between atrial shunt placement and sham in the endpoint of CVD death, non-fatal ischemic stroke at 12 months, and rate of total heart failure events at 24 months.

In commemoration of Wear Red Day, here's a breakdown of how US regions differ in cardiovascular disease burden among women.

A systematic review and meta-analysis from a trio of authors argues against the use of government-mandated non-pharmaceutical interventions to curb a pandemic.

Knowing the symptoms and risk factors of CVD unique to women can aid in awareness and prevention efforts.

Dr. Poornima explores improving engagement in women’s cardiovascular care from both a provider and a patient level.

Cardiovascular disease is the leading cause of death for women.

Women with high social isolation and high loneliness scores had a 13.0% - 27.0% higher risk of incident CVD compared to women with low scores.

Dr. Radhakrishnan discusses both the effects of gender bias and why women don't get screened for heart disease.

On Wear Red Day, Dr. Ivanova advocates for increased awareness and diversity in women's cardiovascular care.

A total of 45 studies were selected for the systematic review, with non-White patients being underrepresented across them all.

New findings observing links between visual acuity, disease progression and risk loci could inform new clinical studies of the leading cause of irreversible vision loss.

Future studies should focus on subgroups of patients with Crohn’s disease treated with ustekinumab.

Dr. Greenberg urges the ACIP to update their vaccine guidelines for patients 65 years and older to recommend high-dose flu vaccines.

Monthly IV pegcetacoplan was associated with 39% reduced risk of progression from incomplete to complete RPE and outer retinal atrophy.

February 3 is National Women's Physician Day.

The fifth update from the American College of Rheumatology supports fourth doses of the vaccine for high-risk rheumatic disease patients.

Both single-donor and multiple-donor fecal microbiota transplantation had clinical cure rates over 80%.

The FDA began conducting research to support the development of bioequivalence recommendations for cyclosporine ophthalmic emulsion in 2012.

Our 5 experts return to examine the far-reaching repercussions of the COVID-19 pandemic on the physician burnout crisis.

Investigators added that the meta-analysis contributed to the comparative effectiveness literature for AGA therapies regarding the compared interventions.

Investigators observed significant increases in the rate of encounters with children and adolescents with autism spectrum disorder, as well as those with anxiety and depression.

Less than 5% of patients with IBD treated with azathioprine had white blood count, eGFR, ALT, and neutrophil abnormalities.

Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.

The application for NVX-CoV2373 is supported by promising data from 2 multinational trials conducted prior to the spread of the Omicron variant.

New data show use exceeding the recommended daily dose for sleep aid has increased nearly 4-fold in the last 15 years.

The FDA was prompted to require a safety trial comparing tofacitinib with TNF inhibitors in patients with rheumatoid arthritis.